SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001193125-23-085591
Filing Date
2023-03-30
Accepted
2023-03-30 16:20:57
Documents
1
Group Members
ANTHONY GAUSIGAILINA J. LIEWGARY LEATTHUBERT BIRNERLUC MARENGERESTEFAN FISCHERTVM LIFE SCIENCE INNOVATION I (GP) LTDTVM LIFE SCIENCE INNOVATION I L.P.TVM LIFE SCIENCE VENTURES MANAGEMENT VI L.P.TVM LIFE SCIENCE VENTURES VI GMBH & CO. KG

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d484810dsc13da.htm SC 13D/A 192497
  Complete submission text file 0001193125-23-085591.txt   194645
Mailing Address ONE GATEWAY CENTER (300 WASHINGTON ST.) SUITE 356 NEWTON MA 02458
Business Address ONE GATEWAY CENTER (300 WASHINGTON ST.) SUITE 356 NEWTON MA 02458 (844) 902-6100
Acer Therapeutics Inc. (Subject) CIK: 0001069308 (see all company filings)

IRS No.: 320426967 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-81104 | Film No.: 23780972
SIC: 2834 Pharmaceutical Preparations

Mailing Address PO BOX 309 UGLAND HOUSE CAYMAN ISLAND A1 00000
Business Address PO BOX 309 UGLAND HOUSE CAYMAN ISLAND A1 00000
TVM Life Science Ventures VI LP (Filed by) CIK: 0001318584 (see all company filings)

IRS No.: 000000000
Type: SC 13D/A